Literature DB >> 17309124

Interaction between birthweight and polymorphism in the calcium-sensing receptor gene in determination of adult bone mass: the Hertfordshire cohort study.

Mirjam A Lips1, Holly E Syddall, Tom R Gaunt, Santiago Rodriguez, Ian N M Day, Cyrus Cooper, Elaine M Dennison.   

Abstract

OBJECTIVE: We sought evidence of interaction between single-nucleotide polymorphisms (SNP) in the calcium-sensing receptor (CASR) gene and early life in determination of bone mineral density (BMD) among individuals from the Hertfordshire Cohort Study.
METHODS: Four hundred ninety-eight men and 468 women aged 59-71 years were recruited. A lifestyle questionnaire was administered and BMD at lumbar spine and femoral neck was measured. DNA was obtained from whole blood samples using standard extraction techniques. Five SNP of the CASR gene termed CASRV1 (rs1801725, G-->T, S986A), CASRV2 (rs7614486, T-->G, untranslated), CASRV3 (rs4300957, untranslated), CASRV4 (rs3804592 G-->A, intron), and CASRV5 (rs1393189, T-->C, intron) were analyzed.
RESULTS: Among women the 11 genotype of the CASRV3 SNP was associated with higher lumbar spine BMD within the lowest birthweight tertile, while the opposite pattern was observed among individuals in the highest birthweight tertile (test for interaction on 1 df, p = 0.005, adjusted for age, body mass index, physical activity, dietary calcium intake, cigarette and alcohol consumption, social class, menopausal status, and hormone replacement therapy use). Similar relationships were seen at the total femur (p = 0.042, fully adjusted) with birthweight and at the total femur according to weight at 1 year tertile among women (p < 0.001, fully adjusted). One haplotype was associated with lumbar spine BMD in women (p = 0.008, fully adjusted); these findings were replicated in a second cohort.
CONCLUSION: We have found evidence of an interaction between a SNP of the CASR gene and birthweight in determination of bone mass in a UK female population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309124      PMCID: PMC2136207     

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

1.  Association of birth weight with osteoporosis and osteoarthritis in adult twins.

Authors:  L Antoniades; A J MacGregor; T Andrew; T D Spector
Journal:  Rheumatology (Oxford)       Date:  2003-04-30       Impact factor: 7.580

2.  Genetic determinants of bone mass in adults. A twin study.

Authors:  N A Pocock; J A Eisman; J L Hopper; M G Yeates; P N Sambrook; S Eberl
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

3.  Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women.

Authors:  Robert Young; Fiona Wu; Neil Van de Water; Ruth Ames; Greg Gamble; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

4.  Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women.

Authors:  J Bollerslev; S G Wilson; I M Dick; A Devine; S S Dhaliwal; R L Prince
Journal:  Calcif Tissue Int       Date:  2003-09-29       Impact factor: 4.333

5.  Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women.

Authors:  F Cetani; E Pardi; S Borsari; E Vignali; G Dipollina; V Braga; S Adami; A Pinchera; C Marcocci
Journal:  Eur J Endocrinol       Date:  2003-06       Impact factor: 6.664

6.  Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass.

Authors:  E M Dennison; H E Syddall; S Rodriguez; A Voropanov; I N M Day; C Cooper
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

Review 7.  Molecular genetics of calcium sensing in bone cells.

Authors:  Jesús Purroy; Nigel K Spurr
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

Review 8.  Genetics of calcium-sensing--regulation of calcium levels in the body.

Authors:  Nigel K Spurr
Journal:  Curr Opin Pharmacol       Date:  2003-06       Impact factor: 5.547

9.  Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone.

Authors:  Raúl M Luque; Rhonda D Kineman; Seungjoon Park; Xiao-Ding Peng; Francisco Gracia-Navarro; Justo P Castaño; María M Malagon
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

10.  Effects of sex steroid receptor specificity in the regulation of skeletal metabolism.

Authors:  T F Tözüm; M E Oppenlander; A J Koh-Paige; D M Robins; L K McCauley
Journal:  Calcif Tissue Int       Date:  2004-07       Impact factor: 4.333

View more
  5 in total

Review 1.  Fetal origins of adult disease.

Authors:  Kara Calkins; Sherin U Devaskar
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2011-07

Review 2.  The role of the calcium-sensing receptor in bone biology and pathophysiology.

Authors:  T A Theman; M T Collins
Journal:  Curr Pharm Biotechnol       Date:  2009-04       Impact factor: 2.837

3.  Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans.

Authors:  Jeesun Jung; Tatiana M Foroud; George J Eckert; Leah Flury-Wetherill; Howard J Edenberg; Xiaoling Xuei; Syed-Adeel Zaidi; J Howard Pratt
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

Review 4.  The Hertfordshire Cohort Study: an overview.

Authors:  Holly E Syddall; Shirley J Simmonds; Sarah A Carter; Sian M Robinson; Elaine M Dennison; Cyrus Cooper
Journal:  F1000Res       Date:  2019-01-21

5.  Genetic markers of bone and joint health and physical capability in older adults: the HALCyon programme.

Authors:  Tamuno Alfred; Yoav Ben-Shlomo; Rachel Cooper; Rebecca Hardy; Cyrus Cooper; Ian J Deary; David Gunnell; Sarah E Harris; Meena Kumari; Richard M Martin; Avan Aihie Sayer; John M Starr; Diana Kuh; Ian N M Day
Journal:  Bone       Date:  2012-10-13       Impact factor: 4.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.